Search
+
    SEARCHED FOR:

    DELHIVERY

    Lenskart, Meesho deliver gains of nearly $400 million for SoftBank Vision funds

    Lenskart saw returns of $273 million, the highest among the Vision funds' listed investments, while Meesho gained $121 million, according to SoftBank's earnings presentation released on Tuesday. The gains come as SoftBank continues to monetise its Indian investments, having sold shares worth more than Rs 9,300 crore in Lenskart and Meesho since June.

    UPI sees Diwali boom; AI cracks Captcha

    Diwali spending fuelled a surge in UPI transactions, with both payment volumes and values rising. This and more in today’s ETtech Top 5.

    Rippling steps up AI hiring in India, looks to expand enterprise push

    The firm is hiring principal engineers, senior staff engineers and senior directors among others as the lab focuses on developing core components of Rippling’s global AI platform, Parandekar told ET in an exclusive interaction.

    AMFI reshuffle: Jio Platforms and NSE may get largecap status, Vedanta may become midcap in H1 CY27

    Nuvama expects Jio Platforms and NSE to enter AMFI's largecap category in its H1 CY27 reshuffle, while Vedanta may move to midcap status. The proposed changes also include upgrades and downgrades across midcap and smallcap stocks, with revised market-cap thresholds estimated at Rs 1.12 lakh crore and Rs 36,700 crore.

    Samvat 2083 outlook: 8 triggers that could turn Sensex, Nifty correction into a rally by next Diwali

    Indian equities enter Samvat 2083 after a correction that has made valuations more attractive, but a sustained rally will depend on several triggers. Falling crude oil prices, easing inflation, an earnings recovery, FII buying, an India-US trade deal and continued domestic liquidity could shape the market's trajectory over the next year.

    Samir Arora backed Helios Mid Cap Fund adds Aurobindo Pharma, 2 others, increase stake in Paytm, MCX and 16 others

    Samir Arora-backed Helios Mid Cap Fund added Aurobindo Pharma, Zetwerk and PVR Inox in October, while increasing stakes in Paytm, MCX and 16 other stocks. The fund exited Park Medi World, expanded its portfolio to 77 stocks and reported assets under management of Rs 2,421 crore.

    The Economic Times
    BACK TO TOP